New research evaluates clinical trials investigating post-acute COVID-19 syndrome treatment
Por um escritor misterioso
Descrição
In a recent article published in Clinical Microbiology and Infection, researchers reviewed all registered trials currently investigating potential treatment options for post-acute coronavirus disease 2019 (COVID-19) syndrome (PACS).
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19
Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial - eClinicalMedicine
Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes - eBioMedicine
Study identifies risk factors for long-haul COVID disease in adults - Mayo Clinic News Network
Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event - Journal of Cardiac Failure
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Full article: Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research
Rehabilitation needs following COVID-19: Five-month post-discharge clinical follow-up of individuals with concerning self-reported symptoms - eClinicalMedicine
de
por adulto (o preço varia de acordo com o tamanho do grupo)
